GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Healthcare Professionals Recognize Need for Environmental Impact Assessments in Hospital Operations

by GOAI
Share To

A recent study published in *Health Research Policy and Systems* examines healthcare professionals’ perspectives on the integration of environmental impact assessments (EIAs) within hospital care. The research highlights growing recognition among medical practitioners of the importance of addressing environmental sustainability in healthcare operations. Findings from the study emphasize the need for incorporating EIAs into hospital practices to mitigate ecological harm while maintaining patient care standards.

The study explores how healthcare professionals view the role of EIAs in reducing environmental footprints associated with hospital activities, such as energy consumption, waste management, and resource use. Researchers gathered insights through interviews and surveys conducted across various healthcare settings. Participants identified challenges in implementing EIAs, including limited resources, lack of standardized guidelines, and competing priorities within clinical environments. Despite these obstacles, many respondents acknowledged that integrating environmental considerations into healthcare decision-making is essential for long-term sustainability. The findings suggest a growing awareness among medical professionals about balancing ecological responsibility with effective patient care delivery.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top